MAI Capital Management

Position in NBIX — Neurocrine Biosciences Inc

CIK 1040197 INDEPENDENCE, OH

Position in NBIX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$558,841

+$498,138 QoQ

Shares Held

4,242

+891.1% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

MAI Capital Management holds $12,062,659 across 49 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (4.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	78,883	$9,324,759
2	UTHR	UNITED THERAPEUTICS Corp	1,060	$628,558
3	NBIX	Neurocrine Biosciences Inc This page	4,242	$558,841
4	VTRS	Viatris Inc	31,574	$426,564
5	HLN	Haleon plc	19,682	$197,016
6	ANIP	Ani Pharmaceuticals Inc	2,532	$194,710
7	AMLX	Amylyx Pharmaceuticals, Inc.	9,014	$125,294
8	COLL	Collegium Pharmaceutical, Inc	3,235	$106,981

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$558,841	4,242	+891.1%	Shares	Sole	2026-05-15
2025-12-31	$60,703	428	+237.0%	Shares	Sole	2026-02-13
2025-09-30	$17,828	127	-61.3%	Shares	Sole	2025-11-10
2025-06-30	$41,226	328	+101.2%	Shares	Sole	2025-08-12
2025-03-31	$18,027	163	-41.8%	Shares	Sole	2025-05-15
2024-12-31	$38,220	280	-95.6%	Shares	Sole	2025-02-14
2022-06-30	$625,041	6,412	0.0%	Shares	Sole	2022-07-19
2022-03-31	$601,125	6,412	+13.1%	Shares	Sole	2022-05-10
2021-12-31	$482,658	5,667	+6.7%	Shares	Sole	2022-02-11
2021-09-30	$509,473	5,312	+3.3%	Shares	Sole	2021-11-12
2021-06-30	$500,322	5,141	-0.0%	Shares	Sole	2021-07-19
2021-03-31	$500,156	5,143	+17.4%	Shares	Sole	2021-05-10
2020-12-31	$419,918	4,381	-19.7%	Shares	Sole	2021-02-16
2020-09-30	$524,648	5,456	—	Shares	Sole	2020-10-26
No filing history on record for this holder in this stock.